Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicines which were referred to the Minister of Health under the provisions of section 24 (5) of the Act and are set out in the Schedule hereto:
Schedule
Product: Atacand
Active Ingredient(s): Candesartan cilexetil 16mg
Dosage Form: Tablet
New Zealand Sponsor: AstraZeneca Limited
Manufacturer(s): AstraZeneca AB, Sodertalje, Sweden
Product: Atacand
Active Ingredient(s): Candesartan cilexetil 4mg
Dosage Form: Tablet
New Zealand Sponsor: AstraZeneca Limited
Manufacturer(s): AstraZeneca AB, Sodertalje, Sweden
Product: Atacand
Active Ingredient(s): Candesartan cilexetil 8mg
Dosage Form: Tablet
New Zealand Sponsor: AstraZeneca Limited
Manufacturer(s): AstraZeneca AB, Sodertalje, Sweden
Product: Omniscan
Active Ingredient(s): Gadodiamide 287mg/mL
Dosage Form: Solution for injection
New Zealand Sponsor: Nycomed New Zealand Ltd
Manufacturer(s): Nycomed AS Production, Oslo, Norway
Nycomed Ireland Limited, Carrigtohil, Co. Cork, Eire
Nycomed Puerto Rico Inc, Barceloneta, Puerto Rico
Dated this 4th day of October 2000.
G. R. BOYD, Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 20th day of February 1997).